A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2002
11/13/2002	CN1379781A Novel oligosaccharides, preparation method and pharmaceutical composition containing same
11/13/2002	CN1379772A Substituted indoles for modulating NFKB activity
11/13/2002	CN1379763A Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions
11/13/2002	CN1379762A Beta substituted metalloprotease inhibitors
11/13/2002	CN1379681A therapeutic angiogenic factors and methods for their use
11/13/2002	CN1379675A 24-hydroxyvitamin D, analogs and use thereof
11/13/2002	CN1379669A Valdecoxib compositions
11/13/2002	CN1379668A 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
11/13/2002	CN1378858A Medicine for preventing or treating osteoporosis and its preparing process and application
11/13/2002	CN1378855A Ointment for treating hyperosteogeny
11/13/2002	CN1378849A Chinese medicine for treating femur head necrosis and its preparing process
11/13/2002	CN1378840A Slow-releasing composition of estrogen medicine and its preparing process
11/13/2002	CN1094053C Traditional Chinese medicinal prepns. for treating osteoporosis
11/12/2002	US6479554 Immunotherapeutic agents
11/12/2002	US6479545 Formulation for menopausal women
11/12/2002	US6479538 Cyclic ether vitamin D3 compounds, 1α(OH)3-EPI-vitamin D3 compounds and uses thereof
11/12/2002	US6479519 Inhibitors of cell adhesion; treatment of asthma or inflammatory bowel disease
11/12/2002	US6479517 Treatment of post-menopausal syndrome: osteoporosis, cardiovascular effects such as hyperlipidemia, and estrogen-dependent cancer, particularly breast and uterine cancer
11/12/2002	US6479507 Modulation of these inflammatory cytokines is considered one of the most effective strategies to block chronic inflammation and have positive therapeutic outcomes
11/12/2002	US6479502 Hydroxamic acid derivatives as proteinase inhibitors
11/12/2002	US6479476 Treating menopausal symptoms and osteoporosis in female warm-blooded animals
11/12/2002	US6479469 N-acylated-2-glucosamine derivatives for treating osteoarthritis/inflammatory arthritis, and enhancing cartilage formulation, chondrocyte cell proliferation and glycosaminoglycan production
11/12/2002	US6479460 Pseudopeptidic osteogenic growth polypeptide
11/12/2002	US6479457 Polypeptide comprising at least one effective ionogenic amine ionically bound to polymer; drug delivery systems for the controlled release of pharmaceutical polypeptides
11/12/2002	CA2088289C Pharmaceutically active composition extracted from tanacetum parthenium, process for its extraction, and pharmaceutical composition containing same
11/12/2002	CA2009533C Novel cyclosporin galenic forms
11/07/2002	WO2002088664A2 Control of compactability through crystallization
11/07/2002	WO2002088384A1 Screening method
11/07/2002	WO2002088354A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002	WO2002088317A2 Fusion molecules and methods for treatment of immune diseases
11/07/2002	WO2002088316A2 G-protein coupled receptors
11/07/2002	WO2002088184A1 A molecular marker
11/07/2002	WO2002088167A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
11/07/2002	WO2002088138A1 Novel 4-amino-5,6-substituted thiopheno[2,3-d]pyrimidines
11/07/2002	WO2002088137A1 Pkb-3564 substance with neovascularization inhibitory activity
11/07/2002	WO2002088123A1 Chemical compounds
11/07/2002	WO2002088122A1 Heterocyclic compounds
11/07/2002	WO2002088121A1 Pyrazolo[1,5-a]pyridines and medicines containing the same
11/07/2002	WO2002088118A1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
11/07/2002	WO2002088115A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
11/07/2002	WO2002088113A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	WO2002088111A1 Novel benzylpiperidine compound
11/07/2002	WO2002088110A1 Quinoline derivative having azolyl group and quinazoline derivative
11/07/2002	WO2002088108A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	WO2002088106A2 Cysteine protease inhibitors
11/07/2002	WO2002088100A2 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
11/07/2002	WO2002088097A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	WO2002088095A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002	WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002	WO2002088090A2 Pyrazole derived kinase inhibitors
11/07/2002	WO2002088080A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002088079A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002087747A1 Stable aqueous colloidal dispersion, method for preparing same
11/07/2002	WO2002087626A1 Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same
11/07/2002	WO2002087620A1 Chondrogenesis promoters
11/07/2002	WO2002087607A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
11/07/2002	WO2002087597A1 Oral delivery of macromolecules
11/07/2002	WO2002087596A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
11/07/2002	WO2002087593A1 A method for treating or preventing a functional vitamin b12 deficiency in an individual and to medical compositions for use in said method
11/07/2002	WO2002087563A2 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
11/07/2002	WO2002087562A1 Use of protein and essential amino acids to treat amenorrhea and related disorders
11/07/2002	WO2002087555A2 Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer
11/07/2002	WO2002087548A1 A pharmaceutical tablet having a high api content
11/07/2002	WO2002087513A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002	WO2002087511A2 Modulators of elastase inhibitor secretion
11/07/2002	WO2002087508A2 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/07/2002	WO2002087505A2 3-structure of a whole integrin $g(a)v$g(b)3 extracellular region and uses therefor
11/07/2002	WO2002087496A2 Methods for inhibiting macrophage colony stimulating factor and c-fms-dependent cell signaling
11/07/2002	WO2002087424A2 Treatment and diagnosis of macrophage mediated disease
11/07/2002	WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002	WO2002047697A3 Fractions of snake blood, their preparation and use as therapeutic agents
11/07/2002	WO2002028424A3 Kyberdrug as autovaccines with immune-regulating effects
11/07/2002	WO2001085687A1 Substituted indoles as parp inhibitors
11/07/2002	WO2001034586A3 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity
11/07/2002	WO2001027079A9 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease
11/07/2002	WO2000064420A3 Compositions and methods for treating amyloidosis using sulphonate derivatives
11/07/2002	US20020166132 System for regulating in vivo the expression of a transgene by conditional inhibition
11/07/2002	US20020165617 Phospholipid-coated implants
11/07/2002	US20020165412 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/07/2002	US20020165399 Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists
11/07/2002	US20020165374 Secreted protein HFEAF41
11/07/2002	US20020165361 Antibody for use in the diagnosis and treatment of cell proliferation disorders
11/07/2002	US20020165343 Growth hormone secretagogues
11/07/2002	US20020165273 Carbamate compounds for use in preventing or treating neurodegenerative disorders
11/07/2002	US20020165262 Methods and products relating to 16-HETE analogs
11/07/2002	US20020165255 Prostaglandin agonists such as (3-(methanesulfonylamino-methyl)-phenoxy)-acetic acid methyl ester for preventing/ restoring bone mass loss
11/07/2002	US20020165203 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents
11/07/2002	US20020165186 Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/07/2002	US20020165169 Therapeutic agent of osteoporosis comprising an active ingredient of quercetin derivatives
11/07/2002	US20020165164 New effectors of dipeptidyl peptidase IV for topical use
11/07/2002	US20020165154 Lipoprotein-regulating medicaments
11/07/2002	US20020165119 Method of treating inflammatory conditions by inhibiting cytosolic phospholipase A2
11/07/2002	US20020164758 Enzymatic polypeptide for use in the diagnosis and treatment of allergies, heart and respiratory disorders
11/07/2002	US20020164719 Targeting pharmaceutical agents to injured tissues
11/07/2002	US20020164692 Immune system-related polynucleotides, polypeptides, and antibodies
11/07/2002	US20020164690 Receptor based antagonists and methods of making and using
11/07/2002	US20020164682 Mammalian cerberus-like protein and compositions
11/07/2002	US20020164390 Compositions containing an active fraction isolated from tricholoma conglobatum and methods of use
11/07/2002	US20020164355 Test to detect antibodies; calibration

1 ... 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 ... 820